The type of non-small cell lung cancer (NSCLC) patients have may now influence their treatment regimen and, in turn, survival outcome according to the results of a major study published online in the Journal of Clinical Oncology. NSCLC is the most common type of lung cancer and represents 85 to 90 percent of all lung [...]
Pharma Strategy and Competitive Intelligence
Business intelligence in a biotechnology world
